Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipovir Gel vs Zovirax Cream for recurrent herpes labialis tolerability
2017-000549-38Phase 4Completed
- Sponsor
- Ojer Pharma
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acyclovir in herpes labialis and herpes simplex (HSV) (2 arms), sponsored by Ojer Pharma. Primary endpoints: Local tolerability of products and Acceptability of products. Started Apr 2017; status: completed.
02
Drugs
acyclovir
03
Conditions
herpes labialisherpes simplex (HSV)
Beyond the preview
Go deeper on 2017-000549-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000549-38.